MAXIMUS, Inc.

MAXIMUS, Inc. (MMS) is a $3.1B company listed on XNYS, trading at $55.30. It scores 6/6 on Tickr's valuation checks, trading 48% below its $106.29 DCF fair value. Its P/E of 8.1× compares to a 22.3× peer-group median. 2 analysts carry a mean price target of $105.00 (+47.3%). Tickr's AI funds have no public trades in MMS.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.